Welcome to our dedicated page for A SPAC III Acqsn SEC filings (Ticker: ASPC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings of A SPAC III Acquisition Corp. (ASPC) provide detailed insight into its structure, governance, and progress toward completing an initial business combination. As a British Virgin Islands special purpose acquisition company listed on Nasdaq, ASPC discloses key events and shareholder actions through current reports, proxy statements, and other regulatory documents filed with the U.S. Securities and Exchange Commission.
Among the most significant filings is the definitive proxy statement on Schedule 14A, which explains the Charter Amendment Proposal to extend the company’s termination date for completing a business combination. This document outlines the rationale for the extension, the mechanics of the trust account, the redemption rights of public shareholders, and the potential consequences if no transaction is completed by the applicable deadline. It also describes the Agreement and Plan of Merger with Bioserica International Limited and the planned reincorporation and acquisition mergers involving A SPAC III’s wholly owned subsidiaries.
The Form 8-K filed on October 27, 2025 reports the results of the extraordinary general meeting at which shareholders approved the Charter Amendment Proposal. This filing details the vote counts, the number of shares tendered for redemption, and the effectiveness of the Amended and Restated Memorandum and Articles of Association, which extend the period to consummate a business combination to November 12, 2026.
On this SEC filings page, users can review ASPC’s 8-K current reports, proxy statements, and related exhibits to understand how the SPAC manages its combination period, handles shareholder redemptions, and structures its proposed merger with Bioserica. Stock Titan’s AI-powered tools can help summarize lengthy documents, highlight key terms such as termination dates and redemption conditions, and make it easier to interpret the implications of each filing for holders of ASPC shares and rights.
A SPAC III Acquisition Corp. reported that it has made its PFIC Annual Statement for fiscal year 2025 available to holders of its Class A ordinary shares. The company believes it may be treated as a passive foreign investment company for U.S. tax purposes for that year and is providing data to help U.S. shareholders consider a Qualified Electing Fund election. Because redemptions significantly changed shares outstanding during 2025, the company calculated per-share, per-day figures using a time-segmented approach. For January 1 to October 26, 2025, it shows ordinary earnings of 0 and no net capital gains; for October 27 to December 31, 2025, it reports ordinary earnings of 0.002124334 and no net capital gains. The statement notes that company redemptions are generally treated as dispositions for U.S. tax purposes and strongly encourages shareholders to consult their own tax advisors.
A SPAC III Acquisition Corp., a British Virgin Islands blank check company, filed its annual report describing progress toward completing a business combination and key structural changes. The company raised $60,000,000 in its IPO and related private placements, placing those proceeds in a trust account for future redemptions and a merger.
During 2025 it signed a Merger Agreement with Bioserica International Limited, a BVI holding company with operations primarily in China, valuing the acquisition at $217,860,000, payable in newly issued PubCo Class A and Class B ordinary shares. Shareholders approved extending the deadline to complete a business combination to November 12, 2026, and 5,717,419 Class A ordinary shares were redeemed in connection with that vote. As of December 31, 2025, $2,979,936 remained in the trust account and, as of March 4, 2026, 2,337,481 Class A and 100 Class B ordinary shares were outstanding.
The report emphasizes that the company has not begun operations and will not generate operating revenue until after an initial business combination. It describes extensive legal and regulatory risks tied to acquiring a China-based business, including PRC foreign investment, data security, cybersecurity review, VIE structures, and the Holding Foreign Companies Accountable Act, as well as potential CFIUS review if it acquires certain U.S. businesses.
Mizuho Financial Group, Inc. filed Amendment No. 3 to a Schedule 13G for A SPAC III Acquisition Corp., reporting beneficial ownership of 0 common shares, representing 0.0% of the class as of 12/31/2025.
The filing shows Mizuho has no sole or shared voting or dispositive power over A SPAC III common shares. Mizuho is identified as a parent holding company, and it states the securities were held in the ordinary course of business and not for the purpose of influencing control.
Bank of Montreal and affiliates have filed an amended Schedule 13G reporting that they no longer beneficially own any Class A ordinary shares of ASPAC III Acquisition Corp. The filing lists Bank of Montreal, Bank of Montreal Holding Inc., and BMO Nesbitt Burns Inc. as reporting persons.
Each entity reports beneficial ownership of 0 shares, with 0% of the class, and no sole or shared power to vote or dispose of any shares. The filing states ownership of 5 percent or less of the class and certifies the securities were held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
W. R. Berkley Corporation and Berkley Insurance Company report no current ownership of A SPAC III ACQUISITION CORP. Class A ordinary shares. The amended Schedule 13G/A states they beneficially own 0 shares, representing 0.0% of the class, with the reportable event dated 12/31/2025. The filing confirms they hold no voting or dispositive power over these securities and that their holdings are 5 percent or less of the class.
A SPAC III Acquisition Corp’s major associated investors report no ownership of its Class A ordinary shares. ATW SPAC Management LLC, Kerry Propper and Antonio Ruiz-Gimenez each report beneficial ownership of 0 shares, or 0.0% of the class, as of 12/31/2025.
They also report no sole or shared voting or dispositive power over any shares and state they now own 5 percent or less of the class. The signatories certify the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
A SPAC III Acquisition Corp. entered into an exchange agreement with its sponsor under which the sponsor transferred 1,499,900 Class B ordinary shares to the company in exchange for 1,499,900 newly issued Class A ordinary shares. These new Class A shares carry the same restrictions that applied to the Class B shares, including transfer limits, waiver of redemption rights and an obligation to vote in favor of an initial business combination as described in the IPO prospectus. After this share exchange, the company has 2,337,481 Class A shares and 100 Class B shares outstanding, and the sponsor holds approximately 76.4% of the outstanding Class A shares. The 1,499,900 Class A shares were issued as unregistered equity securities in reliance on the exemption in Section 3(a)(9) of the Securities Act of 1933.
A SPAC III Acquisition Corp. filed its 10-Q, reporting Q3 results and key developments. The company recorded net income of $480,352, driven by interest income of $654,307 on trust investments, offset by general and administrative expenses of $173,955. The trust account held $62,268,671 as of September 30, 2025.
After quarter-end, shareholders redeemed 5,717,419 Class A shares for $59,502,057, leaving about $2.9 million in the trust. Following these redemptions, the Sponsor held approximately 76.4% of 2,337,581 outstanding ordinary shares. The company’s charter extension gives it until November 12, 2026 to complete a merger.
The company signed a merger agreement with Bioserica for total consideration of $217,860,000 in newly issued PubCo shares, subject to customary conditions. Management disclosed substantial doubt about its ability to continue as a going concern if no business combination is completed within the permitted period.
A SPAC III Acquisition Corp. (ASPC) amended its charter to extend the deadline to complete a business combination by 12 months, moving from November 12, 2025 to November 12, 2026, effective October 27, 2025.
Shareholders approved the charter amendment at an extraordinary general meeting on October 27, 2025. Votes cast were 4,178,733 FOR and 2,934,951 AGAINST. As of the October 6, 2025 record date, 8,055,000 ordinary shares were outstanding, and 7,113,684 shares were voted, representing 88.31% of outstanding shares.
An aggregate of 5,717,419 ordinary shares were tendered for redemption in connection with the meeting. Separately, on October 25, 2025, the Sponsor agreed to transfer 100,000 Class B ordinary shares after the consummation of an initial business combination to an unaffiliated third party in exchange for that party voting 621,084 Class A ordinary shares in favor of the amendment.
ASPC seeks shareholder approval to amend its charter to extend the deadline to complete an initial business combination from November 12, 2025 to November 12, 2026. The Board has unanimously approved a proposed merger with Bioserica International Limited that would (i) reincorporate the company through a merger with a Purchaser and (ii) make Bioserica a wholly-owned subsidiary of the surviving entity. Public shareholders may elect cash redemption based on the Trust Account balance; an illustrative per-share redemption price was approximately $10.38 as of October 6, 2025. The Sponsor owns 1,500,000 Founder Shares and 285,000 Private Placement Units; if no combination occurs by the Extended Termination Date those holdings would become worthless. The Sponsor currently does not plan to contribute additional funds to the Trust Account. The proposal does not add funds to the Trust Account; approval would give the company more time to complete the Business Combination but may reduce per-share trust proceeds available to redeeming public shareholders.